Jiang B, Hu L, Dong D, Guo Z, et al. TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis. J Cancer Res Clin Oncol 2023;149:10041-10052.
PMID: 37261522